These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo. Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension. Su X; Riedel ES; Leon LA; Laping NJ Neurourol Urodyn; 2008; 27(3):249-53. PubMed ID: 17598175 [TBL] [Abstract][Full Text] [Related]
4. Enhanced sensitivity to afferent stimulation and impact of overactive bladder therapies in the conscious, spontaneously hypertensive rat. Patra PB; Thorneloe KS J Pharmacol Exp Ther; 2011 Jul; 338(1):392-9. PubMed ID: 21521774 [TBL] [Abstract][Full Text] [Related]
5. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029 [TBL] [Abstract][Full Text] [Related]
6. Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine. Qiao X; Sun G; Clare JJ; Werkman TR; Wadman WJ Br J Pharmacol; 2014 Feb; 171(4):1054-67. PubMed ID: 24283699 [TBL] [Abstract][Full Text] [Related]
7. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis. Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain. Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the antinociceptive effects of voltage-activated Na+ channel blockers in two rat models of neuropathic pain. Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G Eur J Pharmacol; 2003 Jan; 458(3):275-82. PubMed ID: 12504783 [TBL] [Abstract][Full Text] [Related]
10. Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat. Inoue S; Saito M; Tsounapi P; Dimitriadis F; Ohmasa F; Kinoshita Y; Satoh K; Takenaka A BJU Int; 2012 Jul; 110(2 Pt 2):E118-24. PubMed ID: 22146017 [TBL] [Abstract][Full Text] [Related]
11. Long-term administration of prazosin improves bladder storage function: results from a study in spontaneously hypertensive rats. Haga N; Aikawa K; Ishibashi K; Yanagida T; Nomiya M; Takahashi N; Shiomi H; Oguro T; Ogawa S; Yamaguchi O Int J Urol; 2011 Nov; 18(11):785-91. PubMed ID: 21902723 [TBL] [Abstract][Full Text] [Related]
12. Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications. Ingleby-Talecki L; van Dijkman SC; Oosterholt SP; Della Pasqua O; Winter C; Cunnington M; Rebar L; Forero-Schwanhaeuser S; Patel V; Cooper JA; Bahinski A; Chaudhary KW Clin Transl Sci; 2022 Aug; 15(8):1978-1989. PubMed ID: 35579204 [TBL] [Abstract][Full Text] [Related]
13. Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels. Leffler A; Reiprich A; Mohapatra DP; Nau C J Pharmacol Exp Ther; 2007 Jan; 320(1):354-64. PubMed ID: 17005919 [TBL] [Abstract][Full Text] [Related]
14. Optically active mexiletine analogues as stereoselective blockers of voltage-gated Na(+) channels. Franchini C; Carocci A; Catalano A; Cavalluzzi MM; Corbo F; Lentini G; Scilimati A; Tortorella P; Camerino DC; De Luca A J Med Chem; 2003 Nov; 46(24):5238-48. PubMed ID: 14613326 [TBL] [Abstract][Full Text] [Related]
15. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction? Schneider T; Hein P; Bai J; Michel MC J Urol; 2005 Jun; 173(6):2178-81. PubMed ID: 15879883 [TBL] [Abstract][Full Text] [Related]
16. Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction. Krichevsky VP; Pagala MK; Vaydovsky I; Damer V; Wise GJ J Urol; 1999 May; 161(5):1644-50. PubMed ID: 10210432 [TBL] [Abstract][Full Text] [Related]
18. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction. Gillespie JI; Palea S; Guilloteau V; Guerard M; Lluel P; Korstanje C BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512 [TBL] [Abstract][Full Text] [Related]
19. Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder. Yusup A; Akino H; Miwa Y; Oyama N; Aoki Y; Ito H; Tanase K; Matsuta Y; Nakai M; Yokoyama O Eur J Pharmacol; 2007 Dec; 577(1-3):143-9. PubMed ID: 17904547 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the urinary bladder dysfunction in renovascular hypertensive rats. Ramos-Filho AC; Mónica FZ; Franco-Penteado CF; Rojas-Moscoso JA; Báu FR; Schenka AA; De Nucci G; Antunes E Neurourol Urodyn; 2011 Sep; 30(7):1392-402. PubMed ID: 21661033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]